Sunil Healthcare Financial Statements
- Switch to
-
Tabular DataGraph
- Switch to
-
ConsolidatedStandalone
| Y/e 31 Mar | Mar-2020 | Mar-2018 | Mar-2017 | - |
|---|---|---|---|---|
| Growth matrix (%) | ||||
| Revenue growth | (24) | (16) | -- | -- |
| Op profit growth | (133) | (7.60) | -- | -- |
| EBIT growth | (65) | (6) | -- | -- |
| Net profit growth | (210) | (11) | -- | -- |
| Profitability ratios (%) | ||||
| OPM | (6.60) | 15.20 | 13.90 | -- |
| EBIT margin | 5.65 | 12.40 | 11.10 | -- |
| Net profit margin | (7.10) | 4.90 | 4.64 | -- |
| RoCE | 3.58 | 10.80 | -- | -- |
| RoNW | (2.70) | 2.49 | -- | -- |
| RoA | (1.10) | 1.07 | -- | -- |
| Per share ratios () | ||||
| EPS | -- | 4.38 | 4.91 | -- |
| Dividend per share | -- | -- | -- | -- |
| Cash EPS | (11) | (0.30) | 0.68 | -- |
| Book value per share | 44.20 | 46.30 | 41.80 | -- |
| Valuation ratios | ||||
| P/E | -- | 15.50 | 19.30 | -- |
| P/CEPS | (1.40) | (242) | 140 | -- |
| P/B | 0.34 | 1.47 | 2.26 | -- |
| EV/EBIDTA | 5.84 | 7.79 | 8.40 | -- |
| Payout (%) | ||||
| Dividend payout | -- | -- | -- | -- |
| Tax payout | (21) | (29) | (36) | -- |
| Liquidity ratios | ||||
| Debtor days | 187 | 173 | -- | -- |
| Inventory days | 91.20 | 41.70 | -- | -- |
| Creditor days | (107) | (94) | -- | -- |
| Leverage ratios | ||||
| Interest coverage | (0.60) | (2.30) | (2.90) | -- |
| Net debt / equity | 0.96 | 1.18 | 0.95 | -- |
| Net debt / op. profit | (9.50) | 4.01 | 2.70 | -- |
| Cost breakup () | ||||
| Material costs | (41) | (39) | (47) | -- |
| Employee costs | (19) | (14) | (9.80) | -- |
| Other costs | (47) | (32) | (29) | -- |
- Switch to
-
Tabular DataGraph
- Switch to
-
ConsolidatedStandalone
| Y/e 31 Mar( In .Cr) | Mar-2020 | Mar-2018 | Mar-2017 | - |
|---|---|---|---|---|
| Revenue | 70 | 91.60 | 108 | -- |
| yoy growth (%) | (24) | (16) | -- | -- |
| Raw materials | (29) | (36) | (51) | -- |
| As % of sales | 40.80 | 39.30 | 47.40 | -- |
| Employee costs | (13) | (13) | (11) | -- |
| As % of sales | 18.60 | 13.70 | 9.83 | -- |
| Other costs | (33) | (29) | (31) | -- |
| As % of sales | 47.20 | 31.80 | 28.90 | -- |
| Operating profit | (4.60) | 13.90 | 15 | -- |
| OPM | (6.60) | 15.20 | 13.90 | -- |
| Depreciation | (6.10) | (4.80) | (4.30) | -- |
| Interest expense | (7) | (5) | (4.20) | -- |
| Other income | 14.70 | 2.23 | 1.37 | -- |
| Profit before tax | (3) | 6.31 | 7.89 | -- |
| Taxes | 0.63 | (1.80) | (2.90) | -- |
| Tax rate | (21) | (29) | (36) | -- |
| Minorities and other | -- | -- | -- | -- |
| Adj. profit | -- | 4.49 | 5.03 | -- |
| Exceptional items | -- | -- | -- | -- |
| Net profit | (5) | 4.49 | 5.03 | -- |
| yoy growth (%) | (210) | (11) | -- | -- |
| NPM | (7.10) | 4.90 | 4.64 | -- |
- Switch to
-
Tabular DataGraph
| Y/e 31 Mar ( In .Cr) | Mar-2020 | Mar-2018 | Mar-2017 | - |
|---|---|---|---|---|
| Profit before tax | (3) | 6.31 | 7.89 | -- |
| Depreciation | (6.10) | (4.80) | (4.30) | -- |
| Tax paid | 0.63 | (1.80) | (2.90) | -- |
| Working capital | (1.90) | -- | -- | -- |
| Other operating items | -- | -- | -- | -- |
| Operating cashflow | (10) | (0.30) | -- | -- |
| Capital expenditure | 26.60 | -- | -- | -- |
| Free cash flow | 16.20 | (0.30) | -- | -- |
| Equity raised | 72.70 | 69.90 | -- | -- |
| Investments | 0.11 | -- | -- | -- |
| Debt financing/disposal | 4.16 | (2.20) | -- | -- |
| Dividends paid | -- | -- | -- | -- |
| Other items | -- | -- | -- | -- |
| Net in cash | 93.20 | 67.40 | -- | -- |
- Switch to
-
Tabular DataGraph
- Switch to
-
ConsolidatedStandalone
| Y/e 31 Mar ( In .Cr) | Mar-2020 | Mar-2019 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
| Equity capital | 10.30 | 10.30 | 10.30 | 10.30 |
| Preference capital | 0.76 | -- | -- | -- |
| Reserves | 34.30 | 36.50 | 37.20 | 32.70 |
| Net worth | 45.40 | 46.80 | 47.40 | 42.90 |
| Minority interest | ||||
| Debt | 48.70 | 55.10 | 60.60 | 44.50 |
| Deferred tax liabilities (net) | 12.10 | 7.86 | 7.08 | 7.18 |
| Total liabilities | 106 | 110 | 115 | 94.60 |
| Fixed assets | 70 | 71.30 | 71.10 | 59.80 |
| Intangible assets | ||||
| Investments | 0.11 | 0.11 | 0.10 | -- |
| Deferred tax asset (net) | 6.55 | 1.78 | 1.04 | 1.80 |
| Net working capital | 24.40 | 33.80 | 38.10 | 29.10 |
| Inventories | 24.90 | 16.60 | 10.10 | 10.80 |
| Inventory Days | 130 | -- | 40.40 | 36.30 |
| Sundry debtors | 23.60 | 39.20 | 48.10 | 38.50 |
| Debtor days | 123 | -- | 192 | 130 |
| Other current assets | 6.65 | 7.79 | 7.89 | 5.78 |
| Sundry creditors | (24) | (25) | (19) | (21) |
| Creditor days | 127 | -- | 77.20 | 69.60 |
| Other current liabilities | (6.20) | (5.20) | (8.70) | (5.30) |
| Cash | 5.07 | 2.69 | 4.83 | 3.93 |
| Total assets | 106 | 110 | 115 | 94.60 |
- Switch to
-
ConsolidatedStandalone
| Particulars ( Rupees In Crores.) | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2011 | Dec-2010 |
|---|---|---|---|---|---|
| Gross Sales | 67 | 53.90 | 62 | 30.90 | 29 |
| Excise Duty | -- | -- | -- | -- | -- |
| Net Sales | 67 | 53.90 | 62 | 30.90 | 29 |
| Other Operating Income | -- | -- | -- | 0.54 | 0.20 |
| Other Income | 4.39 | 13 | 0.49 | 0.49 | 0.39 |
| Total Income | 71.40 | 66.90 | 62.50 | 32 | 29.60 |
| Total Expenditure ** | 62.90 | 58.80 | 53.10 | 25.40 | 23.90 |
| PBIDT | 8.49 | 8.06 | 9.46 | 6.60 | 5.70 |
| Interest | 3.93 | 5.24 | 5 | 1.29 | 1.80 |
| PBDT | 4.55 | 2.82 | 4.47 | 5.31 | 3.90 |
| Depreciation | 4.60 | 4.49 | 4.30 | 2.40 | 2.37 |
| Minority Interest Before NP | -- | -- | -- | -- | -- |
| Tax | 0.05 | 0.02 | 0.31 | 0.99 | 0.41 |
| Deferred Tax | (0.10) | -- | 0.07 | -- | -- |
| Reported Profit After Tax | -- | (1.70) | (0.20) | 1.92 | 1.12 |
| Minority Interest After NP | -- | -- | -- | -- | -- |
| Net Profit after Minority Interest | -- | (1.70) | (0.20) | 1.92 | 1.12 |
| Extra-ordinary Items | -- | -- | -- | -- | -- |
| Adjusted Profit After Extra-ordinary item | -- | (1.70) | (0.20) | 1.92 | 1.12 |
| EPS (Unit Curr.) | -- | (1.60) | (0.20) | 1.87 | 1.20 |
| Book Value (Unit Curr.) | -- | -- | -- | -- | -- |
| Dividend (%) | -- | -- | -- | -- | -- |
| Equity | 10.30 | 10.30 | 10.30 | 10.30 | 9.32 |
| Public Shareholding (Number) | -- | -- | -- | -- | -- |
| Public Shareholding (%) | -- | -- | -- | -- | -- |
| Pledged/Encumbered - No. of Shares | -- | -- | -- | -- | -- |
| Pledged/Encumbered - % in Total Promoters Holding | -- | -- | -- | -- | -- |
| Pledged/Encumbered - % in Total Equity | -- | -- | -- | -- | -- |
| Non Encumbered - No. of Shares | -- | -- | -- | -- | -- |
| Non Encumbered - % in Total Promoters Holding | -- | -- | -- | -- | -- |
| Non Encumbered - % in Total Equity | -- | -- | -- | -- | -- |
| PBIDTM(%) | 12.70 | 14.90 | 15.30 | 21.30 | 19.60 |
| PBDTM(%) | 6.79 | 5.23 | 7.21 | 17.20 | 13.40 |
| PATM(%) | (0.10) | (3.10) | (0.40) | 6.21 | 3.86 |
